Investor FAQs

Investor FAQs

Show all

Denali Therapeutics Inc. was incorporated in Delaware in October 2013
Denali is headquartered in South San Francisco, CA.
Denali's fiscal year ends December 31st
Ernst & Young LLP is Denali's independent registered public accounting firm
Denali is traded on the NASDAQ Global Select Stock Market under the ticker symbol "DNLI"

Denali initial public offering occurred on December 8, 2017
24823R 105
American Stock Transfer & Trust Company
(800) 937-5449 (Toll-free)
(718) 921-8124 (International)

American Stock Transfer & Trust Company Operations Center
6201 15th Avenue
Brooklyn, NY 11219
Electronic copies of our Annual Report and other periodic reports are available on this website. If you would like to request paper copies of the Annual Report or other periodic reports, send your request in writing to:

Denali Therapeutics Inc.
Attn: Corporate Secretary
151 Oyster Point Blvd
South San Francisco, CA 94080
Please use the Investor Contact form at the bottom of the page for additional questions or inquiries.